Latest Breaking News On - Company or innocan - Page 19 : comparemela.com

Innocan Pharma Corporation: Innocan Pharma Received Proceeds of CAD $8 2M from the Exercise of Warrants since January 1, 2021

Innocan Pharma Corporation: Innocan Pharma Received Proceeds of CAD $8 2M from the Exercise of Warrants since January 1, 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Israel generalTel avivIris bincovichInnocan pharmaOdyssey trust companyCompany or innocanSolsken ltd tamarInnocan pharma corporationCompany warrant agentLytham partnersHebrew university of jerusalemTamar innovestCanadian securities exchangeAlberta newsfile corpTel aviv universityPharma corporation

Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University

Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel generalTel avivIris bincovichIris bincovichinnocanKeren primor cohenNataly yom tovInnocan pharmaIris bincovich innocanLytham partnersCompany or innocanHebrew university of jerusalemAlberta newsfile corpInnocan pharma corporationTel aviv universityTechnology transfer company of tel aviv universityWall street

Innocan Pharma Corporation: Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - August 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that,

Israel generalTel avivIris bincovichKeren primor cohenNataly yom tovInnocan pharmaIris bincovich innocanLytham partnersCompany or innocanHebrew university of jerusalemAlberta newsfile corpInnocan pharma corporationTel aviv universityTechnology transfer company of tel aviv universityPharma corporationTechnology transfer company

Innocan Pharma Corporation: Innocan Engages Ayurcann Inc to Manufacture and Distribute Innocan s CBD Topicals in Canada

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - August 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce its been

Israel generalTel avivIris bincovichIgal sudmanInnocan pharmaCompany or innocanEndless sky incorporatedLiposome research of the hebrew universityInnocan pharma corporationLytham partnersHead of the laboratory membraneInnocan pharma ltdHebrew university of jerusalemHealth canadaAlberta newsfile corpTel aviv university

Innocan Pharma Corporation: Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)

(3) Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - August 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the Company or Innocan ), is pleased to issue an update on its cutting-edge pre-clinical studies and on the development progress of its Liposome/CBD delivery platform (LPT). These studies are led by Dr. Ahuva Cern and Prof. Chezy Barenholz of The Hebrew University of Jerusalem. To date, Innocan completed two pre-clinical trials on animals. The first trial demonstrated no side effects, while the duration of a single intra-muscular injection resulted in the presence of a high level of CBD for at least 3 weeks in the plasma. In the second trial, the researchers observed the effect of CBD in a disease model of the central nervous system, while CBD was detected for a period of over 7 weeks, after 2 injections.

Israel generalTel avivHebrew universityIris bincovichChezy barenholzInnocan pharmaDevelopment company yissumCompany or innocanInnocan pharma corporationLiposome research departmentLytham partnersInnocan pharma ltdHebrew university of jerusalemAlberta newsfile corpTel aviv universityYissum research